What's Next for Biotech in 2015?

By The Life Science Report

Thursday, 15 January 2015 08:42

Are life sciences stocks in a bubble? Will this be the year biotech overshadows big pharma? Can you fit one more meeting in the schedule? (A reported 4,400 official one-on-one partnering events occurred during the Biotech Showcase 2015, with thousands more cards exchanged in hallways and ballrooms.)

Now that the PowerPoint presentations are being put away and the after-parties are winding down, The Life Sciences Report collected the burning questions and sage insights posted on Twitter during the three-day Biotech Showcase, which was attended by more than 200 people. What were the highlights for you? Did you make the connection that will make all the difference? Are you already making plans for next year?

The latest BUZZ from the Conference

Venture fund manager: "Life Science companies need to plan for financing constraints starting in 18 months. Raise money now!" #BTS15

Overheard in an elevator at #BTS2015 "You would be surprised how many tests are funded by the DoD." #Biotech #DoD


	"Answer the big question for a lot of patients and you will get funding."- Bruce Booth, Atlas Venture #BTS2015


	Are new funding streams for life science companies really here to stay? #BTS2015

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites